Clinical Trials

Mesothelioma

NCT00357747 2023-08-04

AEG35156 and Docetaxel in Treating Patients With Solid Tumors

10 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00372736 2023-08-04

AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors

27 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00504296 2023-08-04

SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

39 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT01486368 2023-08-04

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

17 enrolled

Mesothelioma, Malignant

NCT00101283 2023-07-03

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

32 enrolled 8 charts

Mesothelioma, Malignant, Mesothelioma

NCT00673257 2020-04-14

Pharmacokinetics of Daunorubicin in Young Patients With Cancer

Phase NA Completed

107 enrolled 8 charts

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00003891 2020-04-09

Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors

37 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003890 2020-04-06

MG98 in Treating Patients With Advanced Solid Tumors

19 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003684 2020-04-03

Theophylline in Treating Cancer Patients With Shortness of Breath

Phase 3 Completed

3 enrolled

Pulmonary Complications

NCT00770120 2020-03-06

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

61 enrolled 14 charts

Mesothelioma, Malignant

NCT00690469 2019-10-08

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

234 enrolled

Retinoblastoma

NCT00458913 2018-07-12

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

82 enrolled

Mesothelioma, Malignant

NCT02164838 2018-01-29

VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors

51 enrolled

Refractory or Recurrent Solid Tumors, Excluding CNS Tumors

NCT00897442 2016-10-28

Collecting Tumor Samples From Patients With Gynecological Tumors

DermatologicGynecologicOther solid neoplasmSarcomaThoracic

275 enrolled

Ovarian Germ Cell Cancer, Mesothelioma, Malignant, Brenner Tumor, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Melanoma, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Sarcoma, Endometrial Stromal, Gestational Trophoblastic Disease

NCT02764398 2016-05-11

Cardio-respiratory Events During Ophthalmic Artery Chemotherapy for Retinoblastoma Under a Deep Anesthesia

32 enrolled

Retinoblastoma

NCT01798654 2016-02-19

EUS-FNA for Patients With Antithrombotic Agents

84 enrolled

Solid Tumor

NCT00513877 2014-12-31

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

33 enrolled

Mesothelioma, Malignant

NCT00003597 2014-07-24

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

CNSClassical hematologyDermatologicGenitourinaryGynecologicOther solid neoplasmSarcoma

16 enrolled

Uveal Melanoma, Astrocytoma, Carcinoma, Renal Cell, Medulloblastoma, Melanoma, Neoplasms, Wilms Tumor, Neuroblastoma, Neutropenia, Retinoblastoma, Osteosarcoma, Testicular Neoplasms, Thrombocytopenia, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Gestational Trophoblastic Disease

NCT00008424 2014-05-05

Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants

7 enrolled

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00006095 2014-02-21

Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

20 enrolled

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00006463 2014-02-21

Ecteinascidin 743 in Treating Children With Refractory Solid Tumors

13 enrolled

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00070473 2014-02-20

Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors

33 enrolled

Unspecified Childhood Solid Tumor, Protocol Specific

NCT01048892 2014-01-30

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

CNSEndocrineGenitourinaryOther solid neoplasmSarcoma

22 enrolled

Kidney Neoplasms, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Adrenocortical Carcinoma

NCT00387504 2013-09-12

Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

21 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00433394 2013-06-27

Registration and Informed Consent Study for the Childhood Cancer Research Network

Phase NA Completed

2,242 enrolled

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00003723 2012-10-08

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

57 enrolled

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00004886 2012-09-24

MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors

30 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00045019 2012-08-27

Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care

795 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006354 2012-07-24

Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

41 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00027677 2012-07-24

Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors

25 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004254 2012-07-18

Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed

25 enrolled

Mesothelioma, Malignant

NCT00004920 2012-07-18

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

Phase 3 Completed

256 enrolled

Mesothelioma, Malignant

NCT00005061 2012-07-18

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

20 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006477 2012-07-18

Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors

26 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00227630 2012-07-18

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

59 enrolled

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00003976 2012-07-11

E7070 in Treating Patients With Solid Tumors

30 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003981 2012-07-11

E7070 in Treating Patients With Solid Tumors

30 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00002904 2012-07-02

Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors

40 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003028 2012-07-02

MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors

5 enrolled

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006246 2009-10-07

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer